Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Michelle Fullard

Concepts (113)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Parkinson Disease
21
2026
614
4.710
Why?
Deep Brain Stimulation
3
2026
223
1.520
Why?
Olfaction Disorders
4
2021
74
1.200
Why?
Patient Acceptance of Health Care
3
2026
881
1.030
Why?
Cognitive Dysfunction
5
2021
481
0.900
Why?
Decision Support Techniques
2
2026
478
0.840
Why?
Decision Making
1
2024
993
0.500
Why?
Patient Readmission
2
2020
778
0.500
Why?
Arthroplasty, Replacement, Hip
1
2020
193
0.500
Why?
Vitamin D Deficiency
1
2017
189
0.440
Why?
Arthroplasty, Replacement, Knee
1
2020
385
0.420
Why?
Vitamin D
1
2017
402
0.400
Why?
Physical Therapy Modalities
1
2017
341
0.400
Why?
Length of Stay
1
2020
1358
0.390
Why?
Aged
18
2026
26432
0.380
Why?
Patient Discharge
1
2020
997
0.370
Why?
Sex Characteristics
1
2017
801
0.350
Why?
Medicare
4
2019
920
0.350
Why?
Healthcare Disparities
2
2019
733
0.340
Why?
Middle Aged
14
2026
36619
0.260
Why?
Dementia
2
2023
324
0.240
Why?
Aged, 80 and over
7
2026
8391
0.240
Why?
Endarterectomy, Carotid
1
2026
63
0.230
Why?
Male
18
2026
73396
0.230
Why?
Alzheimer Disease
2
2023
641
0.220
Why?
Carotid Stenosis
1
2026
103
0.220
Why?
Female
17
2026
79499
0.210
Why?
Patient Selection
2
2026
728
0.200
Why?
Humans
23
2026
146342
0.190
Why?
Clinical Decision-Making
1
2026
365
0.190
Why?
Lewy Body Disease
1
2023
33
0.180
Why?
Cannabidiol
1
2024
142
0.170
Why?
Endovascular Procedures
1
2026
390
0.170
Why?
Dronabinol
1
2024
251
0.160
Why?
Disease Progression
5
2025
2867
0.160
Why?
United States
6
2024
16136
0.150
Why?
Cholinergic Antagonists
1
2019
24
0.140
Why?
Cholinesterase Inhibitors
1
2019
47
0.140
Why?
Leukoencephalopathies
1
2018
23
0.140
Why?
Medication Errors
1
2019
86
0.130
Why?
Elective Surgical Procedures
1
2020
216
0.130
Why?
Geography, Medical
1
2017
11
0.130
Why?
Attitude of Health Personnel
1
2026
1219
0.130
Why?
Cohort Studies
3
2017
6077
0.130
Why?
Palliative Care
1
2026
1032
0.130
Why?
Dopamine Plasma Membrane Transport Proteins
1
2017
59
0.130
Why?
Databases, Factual
2
2020
1493
0.120
Why?
White Matter
1
2018
169
0.120
Why?
Drug Prescriptions
1
2019
314
0.120
Why?
Proportional Hazards Models
2
2019
1331
0.120
Why?
Biomarkers
2
2019
4340
0.120
Why?
REM Sleep Behavior Disorder
1
2016
17
0.120
Why?
Diagnosis, Differential
2
2017
1503
0.110
Why?
Risk
1
2017
920
0.110
Why?
tau Proteins
1
2016
111
0.110
Why?
Neuropsychological Tests
2
2018
1149
0.110
Why?
Longitudinal Studies
3
2019
3017
0.110
Why?
Cognition Disorders
1
2018
559
0.100
Why?
Salivary Ducts
1
2013
2
0.100
Why?
Myelitis, Transverse
1
2013
4
0.100
Why?
Carcinoma, Ductal
1
2013
10
0.100
Why?
Parotid Neoplasms
1
2013
14
0.100
Why?
Spinal Cord Neoplasms
1
2013
40
0.100
Why?
Amyloid beta-Peptides
1
2016
251
0.100
Why?
Proteomics
1
2019
1203
0.090
Why?
Logistic Models
1
2017
2126
0.090
Why?
Incidence
1
2017
2936
0.080
Why?
Prevalence
1
2017
2861
0.080
Why?
Cognition
1
2018
1292
0.080
Why?
Prognosis
1
2017
4351
0.070
Why?
Health Knowledge, Attitudes, Practice
2
2026
1408
0.060
Why?
Brain
1
2018
2991
0.060
Why?
Exercise
1
2018
2213
0.060
Why?
Age of Onset
1
2025
558
0.050
Why?
Risk Factors
3
2025
10921
0.050
Why?
Vulnerable Populations
1
2024
178
0.050
Why?
Community-Based Participatory Research
1
2024
172
0.050
Why?
Home Care Services
1
2026
293
0.050
Why?
Patient Participation
1
2026
457
0.040
Why?
Minority Groups
1
2024
286
0.040
Why?
Educational Status
1
2024
466
0.040
Why?
Stents
1
2026
554
0.040
Why?
Disease Management
1
2025
651
0.040
Why?
Retrospective Studies
1
2020
17438
0.040
Why?
Adult
3
2020
41087
0.040
Why?
Treatment Outcome
2
2026
11821
0.040
Why?
Smell
1
2021
129
0.040
Why?
Amidohydrolases
1
2019
31
0.040
Why?
Osteopontin
1
2019
37
0.040
Why?
Drug Incompatibility
1
2019
1
0.040
Why?
Proteoglycans
1
2019
111
0.040
Why?
Double-Blind Method
1
2024
2070
0.040
Why?
Extracellular Matrix Proteins
1
2019
156
0.030
Why?
Social Class
1
2019
260
0.030
Why?
Neurodegenerative Diseases
1
2019
147
0.030
Why?
Acute Disease
1
2019
1038
0.030
Why?
Hospitalization
1
2026
2475
0.030
Why?
Carrier Proteins
1
2019
728
0.030
Why?
Internationality
1
2016
156
0.030
Why?
Resistance Training
1
2018
186
0.030
Why?
Life Style
1
2018
496
0.030
Why?
Comorbidity
1
2019
1665
0.030
Why?
Self Report
1
2018
870
0.020
Why?
Thoracic Vertebrae
1
2013
90
0.020
Why?
Fatal Outcome
1
2013
302
0.020
Why?
Syndrome
1
2013
380
0.020
Why?
Algorithms
1
2019
1849
0.020
Why?
Reproducibility of Results
1
2019
3416
0.020
Why?
Radiography
1
2013
861
0.020
Why?
Cross-Sectional Studies
1
2019
5899
0.020
Why?
Follow-Up Studies
1
2016
5439
0.010
Why?
Magnetic Resonance Imaging
1
2018
3926
0.010
Why?
Prospective Studies
1
2016
8123
0.010
Why?
Fullard's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)